Archives: Resources

Discover how at-home eCOA supported participant compliance, data quality and early oncology trial insights across three Phase I studies.

Explore regulatory considerations for incorporating patient-reported outcomes into oncology trials to support patient-centered evidence.

Discover how standardized MRI, PET and ECG data collection supported evidence generation in a complex global Alzheimer’s disease study.

Explore how centralized ECG data collection improves consistency, safety oversight and regulatory readiness in clinical trials.

Discover how innovative endpoints in early phase oncology trials support earlier insights across efficacy, safety and patient experience.

Explore how diverse endpoint strategies allow sponsors to assess safety, efficacy and broader health impacts in obesity and GLP-1 trials.

Explore how early scientific engagement enables biotechs to optimize trial design, endpoint strategy, data quality and regulatory planning.

Explore how patient-reported outcomes and eCOA strategy capture quality-of-life data that differentiates oncology treatments.

Explore how cognitive assessments and wearable sensor-based gait measures are being studied in Alzheimer’s disease and mild cognitive impairment.